Status:
COMPLETED
Incretin Hormones in Type-1 Diabetes Mellitus Glycemic Response in Type-1 Diabetes Mellitus
Lead Sponsor:
Hvidovre University Hospital
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
18-60 years
Brief Summary
The purpose of this study is to investigate whether secretion of incretin hormones is intact and to what extent endogenous as well as exogenous GLP-1 controls postprandial glucose excursions in patien...
Detailed Description
GLP-1 and GIP are incretin hormones secreted from specific endocrine celles in the gut. Stimulus for secretion is prescence of carbohydrates, fat and protein in the gut. The incretin hormones controls...
Eligibility Criteria
Inclusion
- type-1 diabetes mellitus
- diagnosis between 5-40 years.
- age 18-60 year
- normal weight at time of diagnosis
- insulintreatment from diagnosis
- HbA1c \< 7.6 %
Exclusion
- diabetic complications
- disease other than type-1 diabetes
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00832741
Start Date
May 1 2008
End Date
October 1 2008
Last Update
January 30 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hvidovre University Hospital
Hvidovre, Denmark, 2650